Rating History for Acadia Pharmaceuticals (ACAD) by Mizuho

More Stocks Rated by Mizuho | Latest Ratings for ACAD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/23/2026 Uy Ear Upgrade Outperform
(Neutral)		 35.00
(29.00)		 24.33
(22.16)		 -8.92% Details